{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:35:36Z","timestamp":1793352936460,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New-onset atrial fibrillation (NOAF) following ST-segment elevation myocardial infarction (STEMI) is associated with increased morbidity and mortality. Magnesium (Mg), a key regulator of cardiac electrophysiology, has been implicated in arrhythmogenesis; however, its predictive value for NOAF in STEMI remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 2426 consecutive STEMI patients who underwent primary percutaneous coronary intervention (p-PCI). Patients were categorized based on the occurrence of NOAF during hospitalization. Clinical, laboratory, and procedural data were compared between groups. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify independent predictors and determine the optimal Mg threshold for NOAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      NOAF occurred in 109 (4.5%) patients. Patients with NOAF had significantly lower serum Mg levels (median: 1.70 vs. 2.10\u2005mg\/dl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001) and a higher proportion of Killip Class greater than 1. ROC analysis identified a Mg threshold of less than 1.88\u2005mg\/dl for predicting NOAF (area under the curve: 0.757; sensitivity: 71.5%, specificity: 78.1%). Low Mg was an independent predictor of NOAF in multivariable logistic regression analysis (odd ratio: 2.45; 95% confidence interval: 1.60\u20134.14;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Admission serum Mg level is an independent predictor of NOAF in STEMI patients undergoing p-PCI. Mg assessment may support risk stratification and guide preventive strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001652","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:00:09Z","timestamp":1780383609000},"page":"591-596","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum magnesium predicts new-onset atrial fibrillation in ST-segment elevation myocardial infarction patients after primary percutaneous coronary intervention"],"prefix":"10.1097","volume":"37","author":[{"given":"G\u00f6khan","family":"\u00c7i\u00e7ek","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Ankara City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sad\u0131k Kadri","family":"A\u00e7\u0131kg\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Ankara City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eser","family":"A\u00e7\u0131kg\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat O\u011fuz","family":"Ozilhan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Ankara City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2014.08.037","article-title":"Short- and long-term cause of death in patients treated with primary PCI for STEMI.","volume":"64","author":"Pedersen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ijcard.2012.12.057","article-title":"Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study.","volume":"168","author":"Krijthe","year":"2013","journal-title":"Int J Cardiol"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction.","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/heartjnl-2015-308678","article-title":"All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.","volume":"102","author":"Batra","year":"2016","journal-title":"Heart"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.110.990192","article-title":"Atrial fibrillation and death after myocardial infarction: a community study.","volume":"123","author":"Jabre","year":"2011","journal-title":"Circulation"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1378\/chest.06-2733","article-title":"Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke.","volume":"132","author":"Siu","year":"2007","journal-title":"Chest"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CRD.0000000000000003","article-title":"Role of magnesium in cardiovascular diseases.","volume":"22","author":"Kolte","year":"2014","journal-title":"Cardiol Rev"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.abb.2006.10.014","article-title":"Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium.","volume":"458","author":"Mubagwa","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCULATIONAHA.111.082511","article-title":"Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.","volume":"127","author":"Khan","year":"2013","journal-title":"Circulation"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1253\/circj.CJ-12-0886","article-title":"Serum and dietary magnesium and incidence of atrial fibrillation in Whites and in African Americans \u2013 Atherosclerosis Risk in Communities (ARIC) study.","volume":"77","author":"Misialek","year":"2013","journal-title":"Circ J"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/archinte.1986.00360170068010","article-title":"Magnesium and acute myocardial infarction. Transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction.","volume":"146","author":"Rasmussen","year":"1986","journal-title":"Arch Intern Med"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/00033197251314629","article-title":"The role of magnesium levels in the progression of contrast-induced nephropathy in patients with STEMI undergoing primary PCI.","volume":"76","author":"Demirtola","year":"2025","journal-title":"Angiology"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCA.0000000000000318","article-title":"Magnesium as a predictor of acute stent thrombosis in patients with ST-segment elevation myocardial infarction who underwent primary angioplasty.","volume":"27","author":"\u00c7i\u00e7ek","year":"2016","journal-title":"Coron Artery Dis"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1076029616658119","article-title":"The importance of magnesium values in patients with stemi admitted to the emergency department.","volume":"23","author":"Yuksel","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/eurheartj\/ehp213","article-title":"Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.","volume":"30","author":"Lopes","year":"2009","journal-title":"Eur Heart J"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/CIA.S166100","article-title":"Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA2DS2-VASc scores.","volume":"13","author":"Luo","year":"2018","journal-title":"Clin Interv Aging"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ahj.2014.12.006","article-title":"An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).","volume":"169","author":"Gibson","year":"2015","journal-title":"Am Heart J"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.hrthm.2011.02.016","article-title":"Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction.","volume":"8","author":"Alasady","year":"2011","journal-title":"Heart Rhythm"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1067\/mhj.2002.120410","article-title":"Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: acommunity-wide perspective.","volume":"143","author":"Goldberg","year":"2002","journal-title":"Am Heart J"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1590\/1516-3180.2018.0431140319","article-title":"The CHA2DS2-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study.","volume":"137","author":"Aksoy","year":"2019","journal-title":"Sao Paulo Med J"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/eurheartj\/ehi064","article-title":"Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.","volume":"26","author":"Lehto","year":"2005","journal-title":"Eur Heart J"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCA.0000000000000333","article-title":"Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention.","volume":"27","author":"Karata\u015f","year":"2016","journal-title":"Coron Artery Dis"},{"key":"R27-20261030","first-page":"465","article-title":"Comparison of CHA2DS2-VASc, C2HEST, HAT2CH2, SYNTAX, GRACE, and SYNTAX II scores for predicting new-onset atrial fibrillation complicating acute myocardial infarction.","volume":"53","author":"Do\u011fan","year":"2025","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17520363.2025.2459590","article-title":"The monocyte-to-HDL-cholesterol ratio predicts new-onset atrial fibrillation in patients with acute STEMI.","volume":"19","author":"Tan\u0131k","year":"2025","journal-title":"Biomark Med"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"e948334","DOI":"10.12659\/MSM.948334","article-title":"Platelet-to-lymphocyte ratio as a predictor of atrial fibrillation in STEMI patients.","volume":"31","author":"Li","year":"2025","journal-title":"Med Sci Monit"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/bmm-2020-0838","article-title":"Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction.","volume":"15","author":"Ba\u011fc\u0131","year":"2021","journal-title":"Biomark Med"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/ijms19030664","article-title":"Magnesium replacement to protect cardiovascular and kidney damage? lack of prospective clinical trials.","volume":"19","author":"Mu\u00f1oz-Casta\u00f1eda","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0005-2736(71)90044-7","article-title":"The effect of magnesium, ATP, P i, and sodium on the inhibition of the (Na + + K + )-activated enzyme system by g-strophanthin.","volume":"241","author":"Skou","year":"1971","journal-title":"Biochim Biophys Acta"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/6.1.79","article-title":"Electrophysiological effects of magnesium and its interactions with potassium.","volume":"6","author":"Watanabe","year":"1972","journal-title":"Cardiovasc Res"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01883863","article-title":"The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.","volume":"3","author":"Stark","year":"1989","journal-title":"Cardiovasc Drugs Ther"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2015.12.014","article-title":"Database evaluation of the association between serum magnesium levels and the risk of atrial fibrillation in the community.","volume":"205","author":"Markovits","year":"2016","journal-title":"Int J Cardiol"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9149(86)90738-1","article-title":"Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin.","volume":"57","author":"DeCarli","year":"1986","journal-title":"Am J Cardiol"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-8703(70)90394-7","article-title":"Digitalis toxicity and hypomagnesemia.","volume":"79","author":"Seller","year":"1970","journal-title":"Am Heart J"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/hrt.2006.111492","article-title":"Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.","volume":"93","author":"Ho","year":"2007","journal-title":"Heart"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.jvca.2015.08.003","article-title":"New-onset atrial fibrillation after cardiac surgery: pathophysiology, prophylaxis, and treatment.","volume":"30","author":"Lomivorotov","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R40-20261030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/hrt.2004.033811","article-title":"Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis.","volume":"91","author":"Miller","year":"2005","journal-title":"Heart"},{"key":"R41-20261030","first-page":"CD003611","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.","volume":"2013","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s40140-019-00321-4","article-title":"New-onset atrial fibrillation in adult patients after cardiac surgery.","volume":"9","author":"Burrage","year":"2019","journal-title":"Curr Anesthesiol Rep"},{"key":"R43-20261030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.17925\/HI.2025.19.1.6","article-title":"Magnesium for prevention of new-onset postoperative atrial fibrillation following cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.","volume":"19","author":"Ghazizadeh","year":"2025","journal-title":"Heart Int"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.athoracsur.2012.09.008","article-title":"Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis.","volume":"95","author":"Cook","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R45-20261030","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.4022\/jafib.2154","article-title":"Role of prophylactic magnesium supplementation in prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis of 20 randomized controlled trials.","volume":"12","author":"Chaudhary","year":"2019","journal-title":"J Atr Fibrillation"},{"key":"R46-20261030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0003-4975(91)90918-G","article-title":"Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting.","volume":"52","author":"Fanning","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.86.3.774","article-title":"Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction.","volume":"86","author":"Horner","year":"1992","journal-title":"Circulation"},{"key":"R48-20261030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R49-20261030","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0140-6736(92)91828-V","article-title":"Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).","volume":"339","author":"Woods","year":"1992","journal-title":"Lancet"},{"key":"R50-20261030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(02)11278-5","article-title":"Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.","volume":"360","year":"2002","journal-title":"Lancet"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:01:34Z","timestamp":1793350894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001652","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"2025-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}